|
Oct 3
|
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
|
|
Sep 30
|
Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD
|
|
Sep 30
|
Bayer Reports Positive Safety Data on Parkinson's Disease Drug
|
|
Sep 30
|
Is Trending Stock Eli Lilly and Company (LLY) a Buy Now?
|
|
Sep 30
|
Aktis raises $175M to fuel radiopharma drug development
|
|
Sep 30
|
Eli Lilly and Company (LLY) Gets Strong Buy Rating Amid Revenue Growth
|
|
Sep 29
|
This Is the Best Pharma Stock to Invest $1,000 in Right Now
|
|
Sep 28
|
Jim Cramer Reports That Eli Lilly and Company (LLY)’s Donanemab Was Approved in Japan For Treating Early Symptomatic Alzheimer’s Disease
|
|
Sep 28
|
Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
|
|
Sep 28
|
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
|
|
Sep 28
|
Got $1,000? 2 Superior Growth Stocks to Buy and Hold Forever
|
|
Sep 28
|
21 Stocks to Play a ‘Magical Moment’ in Healthcare
|
|
Sep 27
|
Stocks to Buy and Hold for 5 Years
|
|
Sep 27
|
Pharma Stock Roundup: JNJ's 3rd Talc-Related Bankruptcy Filing & More
|
|
Sep 27
|
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
|
|
Sep 26
|
BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rises On Upsized IPO
|
|
Sep 26
|
Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health
|
|
Sep 26
|
Wall Street Analysts Think Lilly (LLY) Is a Good Investment: Is It?
|
|
Sep 26
|
Eli Lilly’s EBGLYSS offers long-term disease control in atopic dermatitis trial
|
|
Sep 25
|
Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan
|